208 related articles for article (PubMed ID: 1959481)
1. Urinary C-peptide as an index of unstable glycemic control in insulin-dependent diabetes mellitus (IDDM).
Cha T; Tahara Y; Ikegami H; Fukuda M; Yoneda H; Yamato E; Yamamoto Y; Noma Y; Shima K; Ogihara T
Diabetes Res Clin Pract; 1991 Sep; 13(3):181-7. PubMed ID: 1959481
[TBL] [Abstract][Full Text] [Related]
2. Improvement in blunted glucagon response to insulin-induced hypoglycemia by strict glycemic control in diabetics.
Katsura M; Kawamori R; Yamasaki Y; Iwama N; Kubota M; Goriya Y; Kajimoto Y; Shichiri M; Kamada T
Diabetes Res Clin Pract; 1993 May; 20(2):93-100. PubMed ID: 8375272
[TBL] [Abstract][Full Text] [Related]
3. A comparison of serum C-peptide response to intravenous glucagon, and urine C-peptide, as indexes of insulin dependence.
Matsuda A; Kamata I; Iwamoto Y; Sakamoto Y; Kuzuya T
Diabetes Res Clin Pract; 1985 Oct; 1(3):161-7. PubMed ID: 3915262
[TBL] [Abstract][Full Text] [Related]
4. Effect of glycemic control on glucose counterregulation during hypoglycemia in NIDDM.
Levy CJ; Kinsley BT; Bajaj M; Simonson DC
Diabetes Care; 1998 Aug; 21(8):1330-8. PubMed ID: 9702443
[TBL] [Abstract][Full Text] [Related]
5. Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance.
Del Prato S; Matsuda M; Simonson DC; Groop LC; Sheehan P; Leonetti F; Bonadonna RC; DeFronzo RA
Diabetologia; 1997 Jun; 40(6):687-97. PubMed ID: 9222649
[TBL] [Abstract][Full Text] [Related]
6. Effect of glyburide on glycemic control, insulin requirement, and glucose metabolism in insulin-treated diabetic patients.
Simonson DC; Delprato S; Castellino P; Groop L; DeFronzo RA
Diabetes; 1987 Feb; 36(2):136-46. PubMed ID: 3100365
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity and reproducibility of urinary C-peptide as estimate of islet B-cell function in insulin-treated diabetes.
Gjessing HJ; Matzen LE; Faber OK; Frøland A
Diabet Med; 1989; 6(4):329-33. PubMed ID: 2524338
[TBL] [Abstract][Full Text] [Related]
8. Beta-cell response to intravenous glucagon in African-American and Hispanic children with type 2 diabetes mellitus.
Taha DR; Castells S; Umpaichitra V; Bastian W; Banerji MA
J Pediatr Endocrinol Metab; 2002 Jan; 15(1):59-67. PubMed ID: 11822582
[TBL] [Abstract][Full Text] [Related]
9. Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus.
Gutniak M; Orskov C; Holst JJ; Ahrén B; Efendic S
N Engl J Med; 1992 May; 326(20):1316-22. PubMed ID: 1348845
[TBL] [Abstract][Full Text] [Related]
10. Residual beta-cell function and metabolic stability in insulin-dependent diabetes mellitus.
Nakamura H; Takagi A; Tsuda A; Momotsu T; Ito S; Shibata A
Tohoku J Exp Med; 1988 May; 155(1):71-80. PubMed ID: 3046059
[TBL] [Abstract][Full Text] [Related]
11. Enhanced glycemic responsiveness to epinephrine in insulin-dependent diabetes mellitus is the result of the inability to secrete insulin. Augmented insulin secretion normally limits the glycemic, but not the lipolytic or ketogenic, response to epinephrine in humans.
Berk MA; Clutter WE; Skor D; Shah SD; Gingerich RP; Parvin CA; Cryer PE
J Clin Invest; 1985 Jun; 75(6):1842-51. PubMed ID: 3891786
[TBL] [Abstract][Full Text] [Related]
12. Diurnal variation of blood ketone bodies in insulin-dependent diabetes mellitus and noninsulin-dependent diabetes mellitus patients: the relationship to serum C-peptide immunoreactivity and free insulin.
Ubukata E
Ann Nutr Metab; 1990; 34(6):333-42. PubMed ID: 2076025
[TBL] [Abstract][Full Text] [Related]
13. Glycosylated serum proteins and glycosylated hemoglobin in the assessment of glycemic control in insulin-dependent and non-insulin-dependent diabetes mellitus.
Beisswenger PJ; Healy JC; Shultz EK
Metabolism; 1993 Aug; 42(8):989-92. PubMed ID: 8345823
[TBL] [Abstract][Full Text] [Related]
14. Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). The DCCT Research Group.
J Clin Endocrinol Metab; 1987 Jul; 65(1):30-6. PubMed ID: 2884229
[TBL] [Abstract][Full Text] [Related]
15. Urine C-peptide creatinine ratio is an alternative to stimulated serum C-peptide measurement in late-onset, insulin-treated diabetes.
Jones AG; Besser RE; McDonald TJ; Shields BM; Hope SV; Bowman P; Oram RA; Knight BA; Hattersley AT
Diabet Med; 2011 Sep; 28(9):1034-8. PubMed ID: 21843301
[TBL] [Abstract][Full Text] [Related]
16. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
[TBL] [Abstract][Full Text] [Related]
17. Residual C-peptide production in type I diabetes mellitus. A comparison of different methods of assessment and influence on glucose control.
Sjöberg S; Gunnarsson R; Ostman J
Acta Med Scand; 1983; 214(3):231-7. PubMed ID: 6362338
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of ambient blood glucose level and degree of obesity on basal serum C-peptide level and the C-peptide response to glucose and glucagon in non-insulin-dependent diabetes mellitus.
Park SW; Ihm SH; Yoo HJ; Park JY; Lee KU
Diabetes Res Clin Pract; 1997 Sep; 37(3):165-71. PubMed ID: 9306037
[TBL] [Abstract][Full Text] [Related]
19. Factors related to glycemic control in IDDM and insulin-treated NIDDM patients in current practice. A comparison of care policies. SIEMTIC Group. Studio Italiano Epidemiologico Multicentrico su Terapia Insulin e Controllo Metabolico.
Garancini MP; Gallus G; Cucinotta D; Rossi A; Riccardi G
Diabetes Care; 1997 Nov; 20(11):1659-63. PubMed ID: 9353604
[TBL] [Abstract][Full Text] [Related]
20. The glycemic index: similarity of values derived in insulin-dependent and non-insulin-dependent diabetic patients.
Wolever TM; Jenkins DJ; Josse RG; Wong GS; Lee R
J Am Coll Nutr; 1987 Aug; 6(4):295-305. PubMed ID: 3611527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
